ZOMDFOQBHealthcare

Zomedica Corp.

Reports in 15d· 2026-05-14

-22.2% · 90d

$0.10

+0.00 (+0.00%)

News

No News Yet

Press releases and SEC filings for ZOMDF will appear here as they are published.

Check back later for updates

Key Data

Market Cap$96.0M

Open$0.10

Prev Close$0.10

Day Range$0.10 – $0.10

52W Range$0.04 – $0.16

Volume131,456

P/E (TTM)—

EPS$-0.08

Dividend Yield—

Beta1.46

Profit Margin-255.57%

Revenue Growth32.60%

Next Earnings2026-05-14(15d)

About

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. It offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system. The company provides therapeutic products, including PulseVet electrohydraulic shockwave therapy platform; and Assisi Loop line of products, including the Assisi Loop, Assisi Loop Lounge, Assisi EquiLoop, and DentaLoop devices that treat pain and inflammation through delivery of targeted pulsed electromagnetic field focused energy. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. is headquartered in Ann Arbor, Michigan.

Healthcare · Medical Devices

141 employees

www.zomedica.com